|
Contact Us
|
RFP
|
Media Center
|
Study Participants
|
Investigators
|
Français
Overview
History
Leadership Team
Executive Committee
Corporate Responsibility
Overview
Phase I-IIa
First-in-Man
Diverse Experience
Modern Facilities
Project Management
Rapid Recruitment
Proof-of-Concept
Bioavailability / Bioequivalence / Biosimilars
Drug Drug Interaction
QT/TQT Capabilities
Special Populations
Bioanalytical
Non-GLP Analysis
Method Development & Validation
Biomarkers
Large Molecule Analysis
Clinical Lab
Assay List
Instrumentation
Phase IIb-III
Biostatistics and Statistical Programming
Clinical Monitoring
Data Management
Feasibility Studies
Global Safety and Pharmacovigilance
Interactive Response Technologies
Investigator Recruitment and Site Management
Medical and Scientific Affairs
Medical Writing
Project Management
Patient Recruitment Services
Program Branding and Communications
Advertising and Promotion
Referral Network Management
Rater Training
Phase IV
Observational Research and Patient Registries
Interventional IIIB/IV Studies
Health Economics and Outcomes Research
Risk Management and Epidemiology
Quality Assurance
Consulting
505(b)(2)
Biostatistics
Business Plan Services
Chemistry, Manufacturing, and Controls (CMC)
Clinical and Product Development
Global Safety and Pharmacovigilance
Pharmacokinetics and Pharmacodynamics (PK/PD)
Regulatory Services
Functional Service Providers
Staffing
Therapeutic Overview
Clinical Development Expertise
Biosimilars
Generics
Pediatrics
Small Molecule Therapeutics
Therapeutic Indications
Cardiovascular
Infectious Diseases/Vaccines
Neuroscience
Oncology
Pain
Overview
Asia Pacific
Europe
Latin America
North America
Overview
Articles
Brochures
Case Studies
Fact Sheets
PharmaNet Publications
Posters
Presentations
Videos/Podcasts/Webinars
White Papers
Overview
FAQ
Job Opportunities
Training Programs
Flexible Staffing
Print
this page
Email to
a Friend
Overview
Articles
Brochures
Case Studies
Fact Sheets
PharmaNet Publications
Posters
Presentations
Videos/Podcasts/Webinars
White Papers
Articles
Global Pediatric Research - Is There a Return on Investment?, Philippa Smit-Marshall, VP and General Manager of Pediatrics and Medical Sciences, Touch Briefings, 2012,Touchhealthsciences.com
(104.44 KB)
Efficient Beginnings, Author, Kellie Malloy, VP Pain & Inflammatory Disease/Cardiovascular and Metabolic, ICT, Clinical Trial Management, May 2012
(193.43 KB)
Comparative Effectiveness Research, Author, Mason Russell, Executive Director, Health Economists and Outcomes Research, International Pharmaceutical Industry, Volume 3, Issue 4
(293.68 KB)
The Advent of Mobile IRT Solutions in Clinical Trials, Author, Charles Gasman, Journal for Clinical Studies, Volume 3, Issue 5
(185.85 KB)
Managing the Use of Research-Grade Kits During Clinical Trials, Author, Dr. Chris Beaver, International Pharmaceutical Industry, Volume 3, Issue 3
(226.71 KB)
Drug-Drug Interactions Studies: a Regulatory and Study Design Perspective, Authors Mario Tanguay and Jean-Francois Gagne, Journal for Clinical Studies, October, 2011
(184.41 KB)
Interview with Chris Beaver, Immunochemistry Services, Bioanalysis Zone, October 15, 2011
(1.68 MB)
Implementing the Voluntary Harmonization Procedure for Accelerated Clinical Trial Approval, Author, Franz Buchholzer, International Pharmaceutical Industry, May 2011.
(131.66 KB)
Pharmacometrics: A Drug Development Paradigm, Author: Pierre-Olivier Tremblay, Life Science Leader, May 2011
(687.24 KB)
The Complexities of Performing Paediatric Clinical Trials and a Review of Paediatrics Regulations, Author, Philippa Smit-Marshall, JCS, May 2011
(205.58 KB)
Factors that Influence Patient Compliance for Observational Studies, Author - Ron Weishaar, Journal for Patient Compliance, April 2011
(245.72 KB)
A New Paradigm, Author Dalvir Gill, European Pharmaceutical Contractor, March 2011
(249.83 KB)
Challenges and practicalities of obtaining parental consent and child assent in paediatric trials
(542.74 KB)
Efficient and Cost-Effective Monitoring for Observational Studies
(1.53 MB)
OBR On Conversation With Dalvir Gill, President, Late Stage Development,September 2010
(181.18 KB)
Observational Research Dispelling the Myths: Understanding a drug's efficacy in the real world
(273.08 KB)
Pediatric Trials: A Worldview
(1.72 MB)
Phase I Efficiency
(173.67 KB)
Post-approval Research: Requirement, Responsibility, Opportunity
Rapid Response: The future of interactive response solutions
(144.73 KB)
The Elderly Patients: A Largely Neglected Orphan Population
(172.63 KB)
Evaluating the Cognitive Effects of Antiepileptic Treatment in Children with Epilepsy, Author Anna La Noce, MD. Journal for Clinical Studies, May 2010
(347.43 KB)